Zygomatic Versus Conventional Dental Implants in Augmented Maxillae
Primary Purpose
Edentulous Maxilla, Resorbed Maxilla, Implant Therapy
Status
Withdrawn
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Zygomatic implant placement
conventional implants and augmentation of maxilla
Sponsored by
About this trial
This is an interventional treatment trial for Edentulous Maxilla
Eligibility Criteria
Inclusion Criteria:
- fully edentulous patients
- atrophic maxilla
- insufficient bone volume for placement of dental implants
- patients with no more than 4mm of bone height sub-antrally
Exclusion Criteria:
- general contraindications to implant surgery
- history of radiation therapy
- immunosuppressed/immunocompromised patients
- patients taking bisphosphonates
- poor oral hygiene
- patients with untreated periodontitis
- uncontrolled diabetes
- pregnancy
- alcohol/drug addiction
- lack of opposite occluding dentition/prosthesis
- restricted mouth opening.
Sites / Locations
- Glasgow Dental Hospital and School
- St John's Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Zygomatic Implants
Bone Graft and Conventional implants
Arm Description
2-4 zygomatic implants inserted into edentulous maxilla with no augmentation/grafting prior to providing patient with dental prosthesis
Edentulous maxilla which is deficient in bone is first grafted using bone grafting material derived from cows and then ordinary implants are placed into the augmented jaw bone approximately 6 monhts after grafting. Patients will be provided with a dental prosthesis following osseointegration.
Outcomes
Primary Outcome Measures
Implant success
Implant failure is defined by implant mobility +/- infection dictating implant removal.
Implant success
Implant failure is defined by implant mobility +/- infection dictating implant removal
Implant success
Implant failure is defined by implant mobility +/- infection dictating implant removal.
Implant Success
Implant failure is defined by implant mobility +/- infection dictating implant removal
Implant Success
Implant failure is defined by implant mobility +/- infection dictating implant removal
Implant success
Implant failure is defined by implant mobility +/- infection dictating implant removal
Secondary Outcome Measures
Complications
Biologic and prosthetic complications will be assessed. Biologic complications include perimplantitis, maxillary sinusitis,abscess, fistula, gingival dehiscence.
Prosthetic complication: abutment fracture
Change in marginal bone levels on intra oral radiographs
To be evaluated on intraoral radiographs taken with the paralleling technique at implant placement, at delivery of the provisional prostheses, 1, 3, 5, 7, 10 and 15 years after loading.
Failure of augmentation procedure
The augmentation procedure will be considered a failure if, after it has been performed, it will not be possible to place the planned implants in the augmented site.
Change in Oral Health impact profile OHIP-14
To be filled in i)at patient enrolment prior to delivering any interventions, ii)12 weeks after delivery of the definitive prostheses and iii) 1, 3, 5, 7, 10 and 15 years after loading. Patients' number of days with total or partial impaired activity assessed at delivery of the provisional prosthesis A days of total impaired activity is one where patient is unable to perform his/her ordinary life activity including work. A days of partial impaired activity is one where the patient is only partially able to perform his/her ordinary life activity including work.
Complications
Biologic and prosthetic complications will be assessed. Biologic complications include perimplantitis, maxillary sinusitis, abscess, fistula, gingival dehiscence Prosthetic complication: abutment fracture
Complications
Biologic and prosthetic complications will be assessed. Biologic complications include perimplantitis, maxillary sinusitis, abscess, fistula, gingival dehiscence Prosthetic complication: abutment fracture
Complications
Biologic and prosthetic complications will be assessed. Biologic complications include perimplantitis, maxillary sinusitis, abscess, fistula, gingival dehiscence Prosthetic complication: abutment fracture
Complications
Biologic and prosthetic complications will be assessed. Biologic complications include perimplantitis, maxillary sinusitis, abscess, fistula, gingival dehiscence Prosthetic complication: abutment fracture
Complications
Biologic and prosthetic complications will be assessed. Biologic complications include perimplantitis, maxillary sinusitis, abscess, fistula, gingival dehiscence Prosthetic complication: abutment fracture
Full Information
NCT ID
NCT01961284
First Posted
September 4, 2013
Last Updated
September 20, 2017
Sponsor
NHS Lothian
Collaborators
NHS Greater Glasgow and Clyde
1. Study Identification
Unique Protocol Identification Number
NCT01961284
Brief Title
Zygomatic Versus Conventional Dental Implants in Augmented Maxillae
Official Title
Zygomatic Versus Conventional Dental Implants in Augmented Maxillae: a Pragmatic Multicentre Randomised Clinical Trial.
Study Type
Interventional
2. Study Status
Record Verification Date
September 2017
Overall Recruitment Status
Withdrawn
Why Stopped
Sponsor company decision to terminate study
Study Start Date
October 2013 (undefined)
Primary Completion Date
August 2017 (Actual)
Study Completion Date
August 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
NHS Lothian
Collaborators
NHS Greater Glasgow and Clyde
4. Oversight
5. Study Description
Brief Summary
Dental implants are used for replacing missing teeth. Placing dental implants is limited by the presence of adequate bone volume permitting their anchorage. In order to solve this problem several bone augmentation procedures have been developed. In principle the missing bone is taken from a donor site (for example the hip), transplanted where needed and then implants are placed. Sometimes, major bone grafting operations have to be undertaken under general anaesthesia requiring patients to be hospitalised for a few days. Some degree of morbidity related to the donor site must be expected, though more recently bone substitutes are used to minimize morbidity, and 2 to 3 surgical interventions may be needed before the implants can be functionally used. Sometimes patients have to wait more than 1 year before a prosthesis can be fixed to the implants and the total cost of the treatment is high. At the beginning of the 1990s a long screwshaped implant was developed by Professor PI Brånemark as an alternative to bone augmentation procedures: the zygomatic implant. Zygomatic implants are generally inserted through the palate to engage the body of the cheek bone. One to three zygomatic implants can be inserted through the posterior palate to engage the body of each cheek bone. The potential main advantages of zygomatic implants could be that bone grafting may not be needed and a fixed prosthesis could be fitted the same day of their placement. Despite that zygomatic implants have been used for more than 20 years, their effectiveness has never been compared with conventional dental implants in augmented maxillae. The aim of the project is to compare the longtermclinical outcome of fullarch upper jaw bridges supported by zygomatic implants versus conventional implants placed in augmented bone in the palate.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Edentulous Maxilla, Resorbed Maxilla, Implant Therapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Zygomatic Implants
Arm Type
Active Comparator
Arm Description
2-4 zygomatic implants inserted into edentulous maxilla with no augmentation/grafting prior to providing patient with dental prosthesis
Arm Title
Bone Graft and Conventional implants
Arm Type
Active Comparator
Arm Description
Edentulous maxilla which is deficient in bone is first grafted using bone grafting material derived from cows and then ordinary implants are placed into the augmented jaw bone approximately 6 monhts after grafting. Patients will be provided with a dental prosthesis following osseointegration.
Intervention Type
Device
Intervention Name(s)
Zygomatic implant placement
Intervention Type
Device
Intervention Name(s)
conventional implants and augmentation of maxilla
Primary Outcome Measure Information:
Title
Implant success
Description
Implant failure is defined by implant mobility +/- infection dictating implant removal.
Time Frame
1 year following implant loading
Title
Implant success
Description
Implant failure is defined by implant mobility +/- infection dictating implant removal
Time Frame
3 years following implant loading
Title
Implant success
Description
Implant failure is defined by implant mobility +/- infection dictating implant removal.
Time Frame
5 years after implant loading
Title
Implant Success
Description
Implant failure is defined by implant mobility +/- infection dictating implant removal
Time Frame
7 years after implant loading
Title
Implant Success
Description
Implant failure is defined by implant mobility +/- infection dictating implant removal
Time Frame
10 years after implant loading
Title
Implant success
Description
Implant failure is defined by implant mobility +/- infection dictating implant removal
Time Frame
15 years after implant loading
Secondary Outcome Measure Information:
Title
Complications
Description
Biologic and prosthetic complications will be assessed. Biologic complications include perimplantitis, maxillary sinusitis,abscess, fistula, gingival dehiscence.
Prosthetic complication: abutment fracture
Time Frame
1 year
Title
Change in marginal bone levels on intra oral radiographs
Description
To be evaluated on intraoral radiographs taken with the paralleling technique at implant placement, at delivery of the provisional prostheses, 1, 3, 5, 7, 10 and 15 years after loading.
Time Frame
1,3,5,7,10,15 years
Title
Failure of augmentation procedure
Description
The augmentation procedure will be considered a failure if, after it has been performed, it will not be possible to place the planned implants in the augmented site.
Time Frame
6 months after augmentation procedure
Title
Change in Oral Health impact profile OHIP-14
Description
To be filled in i)at patient enrolment prior to delivering any interventions, ii)12 weeks after delivery of the definitive prostheses and iii) 1, 3, 5, 7, 10 and 15 years after loading. Patients' number of days with total or partial impaired activity assessed at delivery of the provisional prosthesis A days of total impaired activity is one where patient is unable to perform his/her ordinary life activity including work. A days of partial impaired activity is one where the patient is only partially able to perform his/her ordinary life activity including work.
Time Frame
1,3,5,7,10,15
Title
Complications
Description
Biologic and prosthetic complications will be assessed. Biologic complications include perimplantitis, maxillary sinusitis, abscess, fistula, gingival dehiscence Prosthetic complication: abutment fracture
Time Frame
3 years
Title
Complications
Description
Biologic and prosthetic complications will be assessed. Biologic complications include perimplantitis, maxillary sinusitis, abscess, fistula, gingival dehiscence Prosthetic complication: abutment fracture
Time Frame
5 years
Title
Complications
Description
Biologic and prosthetic complications will be assessed. Biologic complications include perimplantitis, maxillary sinusitis, abscess, fistula, gingival dehiscence Prosthetic complication: abutment fracture
Time Frame
7 years
Title
Complications
Description
Biologic and prosthetic complications will be assessed. Biologic complications include perimplantitis, maxillary sinusitis, abscess, fistula, gingival dehiscence Prosthetic complication: abutment fracture
Time Frame
10 years
Title
Complications
Description
Biologic and prosthetic complications will be assessed. Biologic complications include perimplantitis, maxillary sinusitis, abscess, fistula, gingival dehiscence Prosthetic complication: abutment fracture
Time Frame
15 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
fully edentulous patients
atrophic maxilla
insufficient bone volume for placement of dental implants
patients with no more than 4mm of bone height sub-antrally
Exclusion Criteria:
general contraindications to implant surgery
history of radiation therapy
immunosuppressed/immunocompromised patients
patients taking bisphosphonates
poor oral hygiene
patients with untreated periodontitis
uncontrolled diabetes
pregnancy
alcohol/drug addiction
lack of opposite occluding dentition/prosthesis
restricted mouth opening.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Victor Lopes, PhD
Organizational Affiliation
NHS Lothian
Official's Role
Study Chair
Facility Information:
Facility Name
Glasgow Dental Hospital and School
City
Glasgow
Country
United Kingdom
Facility Name
St John's Hospital
City
Livingston
Country
United Kingdom
12. IPD Sharing Statement
Learn more about this trial
Zygomatic Versus Conventional Dental Implants in Augmented Maxillae
We'll reach out to this number within 24 hrs